How Is The Artificial Intelligence (AI) In Respiratory Diseases Market Expected To Grow At 5% CAGR Over 2025–2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Is The Artificial Intelligence (AI) In Respiratory Diseases Market Expected To Grow In Terms Of Size?
The market size for artificial intelligence (AI) in treating respiratory diseases has progressively expanded in the recent past. The market, which will expand from $7.66 billion in 2024 to $7.98 billion in 2025, predicts a compound annual growth rate (CAGR) of 4.2%. This significant growth during the historic period is a result of enhanced government regulations, rising environmental awareness, an increase in the aging population, a shift towards patient-focused healthcare strategies, and an upsurge in the development of healthcare infrastructures.
The market for artificial intelligence (AI) in respiratory diseases is predicted to steadily expand in the upcoming years, reaching $9.7 billion by 2029 with a compound annual growth rate (CAGR) of 5.0%. This increasing growth throughout the forecast period can be attributed to factors such as a surge in respiratory diseases, the rising demand for early detection and diagnosis, escalating environmental pollution, increased healthcare spending, and research and development endeavors. Key trends observed during the same period include advancements in technology, drug discovery and development, personalized treatment strategies, telemedicine, and remote patient monitoring techniques.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp
What Are The Primary Factors Supporting The Artificial Intelligence (AI) In Respiratory Diseases Market Expansion?
The escalating problem of environmental pollution is projected to drive the expansion of artificial intelligence (AI) in the respiratory disease market. Environmental pollution is described as any material or form of energy that is added to the environment faster than it can be spread or safely stored. The role of AI in respiratory conditions has the potential to dramatically decrease the effect of environmental pollution on respiratory health. This can be achieved through real-time monitoring, individualized risk assessments, knowledgeable decision making, and inventive answers for individuals and communities alike. For example, data from the U.S. Energy Information Administration, a government agency in the U.S., indicated that CO2 emissions in 2021 were at 35.72 billion metric tons and rose to 38.50 billion metric tons in 2022. As a result of this, the increase in environmental pollution is propelling the advancement of AI in the respiratory disease market.
Which Segmentation Categories Are Highlighted In The Artificial Intelligence (AI) In Respiratory Diseases Market Analysis?
The artificial intelligence (AI) in respiratory diseasesmarket covered in this report is segmented –
1) By Imaging Type: Magnetic Resonance Imaging (MRI); Computed Tomography (CT) Scan; Electronic Patient-Reported Outcomes (ePRO)
2) By Indication: Chronic Obstructive Pulmonary Disease; Interstitial Lung Disease; Pulmonary Infection
3) By End Use: Hospital; Diagnostic Centers; Ambulatory Surgical Centers; Other End-Users
Subsegments:
1) By Magnetic Resonance Imaging (MRI): Lung Imaging; Thoracic Imaging; Cardiopulmonary Imaging
2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT); Low-Dose CT; Thoracic CT
3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking; Medication Adherence Monitoring; Quality Of Life Assessments
Which Notable Trends Are Transforming The Artificial Intelligence (AI) In Respiratory Diseases Market Outlook?
Key businesses within the artificial intelligence (AI) sector of the respiratory diseases market, are paving the way with groundbreaking products like N-Tidal devices, which are used to observe tidal breathing in patients. The N-Tidal device keeps track of air volume exchanged during ordinary respiration, effectively providing crucial data about lung functionality. For instance, in August 2023, a revolutionary AI device named N-Tidal was introduced by TidalSense, a leading respiratory technology firm based in the UK, specifically for diagnosing and managing chronic obstructive pulmonary disease (COPD). The unique combination of N-Tidal’s CO2 data with an AI platform enables timely detection of lung function changes, thus enhancing the diagnosis and treatment of this respiratory ailment. The high precision of this technology has been proven through clinical trials, and it promises to revolutionize the diagnostic procedure for respiratory ailments. This product launch marks a substantial progression in the application of AI for evaluating respiratory diseases, providing a more convenient and effective substitute to existing diagnostic examinations.
Which Organizations Are At The Forefront Of The Artificial Intelligence (AI) In Respiratory Diseases Market?
Major companies operating in the artificial intelligence (AI) in respiratory diseases market report are Siemens Healthineers, Philips Healthcare, General Electric (GE) Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Innovaccer, Freenome, Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Gauss Surgical Inc., Swaasa AI, Inspirata Inc., VIDA Diagnostics Inc., Enlitic, Thirona B.v., ArtiQ, Icometrix, Zynnon AG, Aidence, Arterys, Dectrocel Healthcare, PneumoWave Ltd.
Access The Complete Report Here:
Which Geographic Regions Are Creating Strong Demand In The Artificial Intelligence (AI) In Respiratory Diseases Market?
North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=13792&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI) In Respiratory Diseases Market 2025, By The Business Research Company
Artificial Intelligence Of Things Aiot Global Market Report 2025
Artificial Intelligence In Cancer Diagnostics Global Market Report 2025
Artificial Intelligence Ai Engineering Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
